CapEx News

Shilpa Biologicals Commissions GMP-Compliant ADC Manufacturing Facility

Manufacturing Jul 04,2026

Shilpa Biologicals has commissioned a GMP-compliant antibody-drug conjugate (ADC) manufacturing facility to support global biologics and oncology drug development.

Read More

Shilpa Biologicals Commissions Antibody-Drug Conjugate GMP Manufacturing Facility in Dharwad, Karnataka

Hospitality and Healthcare Jun 24,2026

Shilpa Biologicals, a subsidiary of Shilpa Medicare, has commissioned a new Antibody-Drug Conjugate GMP manufacturing facility in Dharwad, Karnataka, built to meet US FDA and EMA regulatory standards.

Read More